Form 4: Movano Inc. Director Shaheen Wirk Reports Stock Option Grants
SEC Form 4 Filing
Director Shaheen Wirk reports the acquisition of stock options in Movano Inc. on January 2, 2025.
Summary
- On January 2, 2025, Shaheen Wirk, a director of Movano Inc., reported the acquisition of two stock option grants.
- The first grant is for 13,300 shares with an exercise price of $5.28, vesting in 48 equal monthly installments starting one month after the grant date, with full vesting upon a change in control.
- The second grant is for 10,000 shares with an exercise price of $5.28, vesting in full on the one-year anniversary of the grant date.
- The expiration date for both options is January 2, 2035.
- Following these transactions, Wirk directly owns 13,300 and 10,000 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it is a routine disclosure of stock option grants to a director, which is a common practice.
Positives
- The granting of stock options to a director aligns their interests with those of the shareholders.
- The vesting schedules provide an incentive for continued service and commitment to the company's success.
Industry Context
Stock option grants are a common form of compensation for directors and executives in publicly traded companies, aligning their interests with shareholders and incentivizing long-term value creation.
Comparison to Industry Standards
- Stock option grants are a standard component of director compensation packages in the technology and healthcare industries, often used to attract and retain talent.
- Vesting schedules, such as the monthly vesting over four years and the one-year cliff vesting, are typical structures designed to incentivize continued service.
Stakeholder Impact
- The stock option grants could potentially dilute existing shareholders if the options are exercised in the future.
- The grants incentivize the director to work towards increasing shareholder value.
Key Dates
| Date | Description |
|---|---|
| 01/02/2025 | Date of stock option grants. |
| 01/06/2025 | Date of Form 4 filing. |
| 01/02/2035 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.